Skip to main content
Clinical Trials/NCT04828044
NCT04828044WithdrawnNot Applicable

Microwave Ablation of Breast Tumors

St. Joseph Hospital of Orange1 site in 1 countryStarted: September 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
1
Primary Endpoint
Amount of tissue destruction with MedWaves Microwave Ablation/ Coagulation System.

Study Overview

Brief Summary

The purpose of this protocol is to pathologically evaluate the amount of destruction of cancer cells by Microwave Ablation (MWA) in primary breast tumors.

Detailed Description

Minimally invasive surgical alternatives are becoming more attractive for the treatment of malignancy due to improvements in technology, reduced costs and reduced morbidity. The main objective of this protocol is to determine the extent of ablation based on time and power parameters of the MedWaves in breast cancers. This would be accomplished in patients diagnosed with breast cancer who are already scheduled for breast cancer surgery. Prior to the surgical removal of the cancer, the microwave antenna would be inserted into the tumor under ultrasound guidance (either percutaneously or open). The tumor would be ablated, and then surgically resected in a standard, curative fashion.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • a diagnosis of primary breast tumor for which a surgical resection (excisional, biopsy, segmentectomy or mastectomy) is planned.
  • Tumor is palpable or visible on ultrasound or both
  • All participants need to be fully able to give informed consent

Exclusion Criteria

  • Gender: male
  • Mental or legal incompetence
  • Impaired decision-making capacity
  • Pregnant women may not participate
  • Implanted Pacemaker

Outcomes

Primary Outcomes

Amount of tissue destruction with MedWaves Microwave Ablation/ Coagulation System.

Time Frame: 30 days

Measure tissue destruction with the MedWaves Microwave Ablation/ Coagulation System through pathological review of destruction.

Secondary Outcomes

  • Amount of toxicity of microwave ablation in patients.(30 Days)
  • Provide the differences between percutaneous and open Microwave Ablation(30 Days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials